Dr. McDermott on Single-Agent Pembrolizumab in Advanced RCC OncLive 1:58 5 years ago 262 Далее Скачать
Dr. McDermott on Single-Agent Versus Combination Immunotherapy in RCC OncLive 1:15 5 years ago 109 Далее Скачать
Dr. McDermott on the Promise of Pembrolizumab in Non-Clear Cell RCC OncLive 1:10 5 years ago 89 Далее Скачать
Dr Rini on a Biomarker Analysis for Pembrolizumab/Axitinib in Advanced RCC OncLive 3:28 3 months ago 55 Далее Скачать
Dr. McDermott on Immunotherapy as a Standard of Care in RCC OncLive 0:54 6 years ago 129 Далее Скачать
Dr. Vaishampayan on Axitinib Plus Pembrolizumab in Advanced RCC OncLive 1:17 4 years ago 872 Далее Скачать
Dr. McDermott on Toxicities of Immunotherapy Combinations in RCC OncLive 1:16 4 years ago 78 Далее Скачать
Dr. Tykodi on the KEYNOTE-427 Trial With Pembrolizumab in RCC OncLive 2:25 4 years ago 219 Далее Скачать
Watch Drs. Choueiri, McDermott, and Tannir, discuss the latest in RCC: https://bit.ly/3n3X59m PeerView Oncology 1:05:38 4 years ago 143 Далее Скачать
Dr. Cost on Pembrolizumab Plus Axitinib in Patients With RCC OncLive 1:56 7 years ago 381 Далее Скачать
